BWOWF yields 20000000.00% · JNJ yields 2.13%● Live data
📍 BWOWF pulled ahead of the other in Year 1
Combined, BWOWF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BWOWF + JNJ for your $10,000?
Wowjoint Holdings Limited provides infrastructure solutions for customized heavy duty lifting and carrying machinery used in various projects worldwide. The company's machine supply products include bridge erection machines, such as launching machines, and MSS and molds; material handling products comprising special carriers, straddle carriers, slab mobilift with double cantilevers, wind power handling equipment, and gantry cranes; and trollies that include tire, flat, and low frame trollies, as well as trollies for transporting railway panels. Its machine supply products also comprise bridge replacement gantries for highway and railway bridges; and marine hoists. In addition, the company offers rental services for equipment, including T-beam launching machines, segment lifters, special launching carriers, special carriers, tire trollies, and mobilift with double cantilevers. Further, it provides various construction and engineering services related to bridge construction and rail services, such as solutions on erection of prefabricated bridge/viaduct and rebuilding replacement of old bridges. Additionally, the company offers subcontracting services comprising job sit services through operating machines for bridge erection, bridge rebuilding, lifting, and transporting at prefabrication yards, as well as equipment move commissioning. The company was founded in 1996 and is based in Beijing, China.
Full BWOWF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.